This inventor holds 3 USPTO granted patents. Top assignees: Beone Medicines I Gmbh, Beigene, Ltd.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Lina Gu - Innovator in Cyclic Dinucleotide Research
Introduction
Lina Gu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cyclic dinucleotide compounds. Her work focuses on creating innovative solutions for various diseases, including cancer and viral infections.
Latest Patents
Lina Gu holds a patent for "Cyclic dinucleotides as STING agonists." This patent discloses cyclic di-nucleotide compounds and their derivatives, which may serve as effective STING agonists. The patent also details the synthesis process and potential applications of these compounds in treating diseases such as cancer, HIV infection, and HBV infection. She has 1 patent to her name.
Career Highlights
Lina Gu is currently employed at BeiGene, Ltd., a leading biotechnology company focused on developing innovative medicines for cancer treatment. Her role at BeiGene allows her to work on cutting-edge research that has the potential to impact patient care significantly.
Collaborations
Lina collaborates with esteemed colleagues, including Jing Li and Zhiwei Wang, who contribute to her research efforts and enhance the innovative environment at BeiGene.
Conclusion
Lina Gu is a dedicated inventor whose work in cyclic dinucleotide research is paving the way for new therapeutic approaches to combat serious diseases. Her contributions to the field exemplify the importance of innovation in healthcare.